Temporal Trends and Predictors in the Use of Stereotactic Body Radiotherapy for Treatment of Metastatic Renal Cell Carcinoma in the U.S

This letter to the editor outlines the use of stereotactic body radiotherapy for metastatic renal cell carcinoma in the U.S., identifying clinical predictors of utilization using the National Cancer Database.

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncologist
Asıl Yazarlar: Paciotti, Marco, Schmidt, Andrew L., Ravi, Praful, McKay, Rana R., Trinh, Quoc‐Dien, Choueiri, Toni K.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Inc. 2021
Konular:
Letters to the Editor
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8100555/
https://ncbi.nlm.nih.gov/pubmed/33650184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13736
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller